FDA Inspection 568770 — AMAG Pharma USA, Inc.
The FDA completed an inspection of AMAG Pharma USA, Inc. on February 2, 2009 in Bridgeton, MO. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- February 2, 2009
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bridgeton, MO (United States)